Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005654 | nucleoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: E9AXS5
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 10 |
GO:0005488 | binding | 1 | 10 |
GO:0097159 | organic cyclic compound binding | 2 | 10 |
GO:1901363 | heterocyclic compound binding | 2 | 10 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 117 | 119 | PF00675 | 0.472 |
CLV_NRD_NRD_1 | 199 | 201 | PF00675 | 0.447 |
CLV_NRD_NRD_1 | 209 | 211 | PF00675 | 0.483 |
CLV_PCSK_KEX2_1 | 116 | 118 | PF00082 | 0.457 |
CLV_PCSK_KEX2_1 | 201 | 203 | PF00082 | 0.459 |
CLV_PCSK_KEX2_1 | 209 | 211 | PF00082 | 0.483 |
CLV_PCSK_PC1ET2_1 | 116 | 118 | PF00082 | 0.457 |
CLV_PCSK_PC1ET2_1 | 201 | 203 | PF00082 | 0.459 |
CLV_PCSK_PC7_1 | 113 | 119 | PF00082 | 0.388 |
CLV_PCSK_SKI1_1 | 113 | 117 | PF00082 | 0.483 |
CLV_PCSK_SKI1_1 | 37 | 41 | PF00082 | 0.426 |
DOC_CYCLIN_RxL_1 | 177 | 187 | PF00134 | 0.603 |
DOC_CYCLIN_yCln2_LP_2 | 107 | 110 | PF00134 | 0.481 |
DOC_MAPK_gen_1 | 160 | 167 | PF00069 | 0.467 |
DOC_PP2B_LxvP_1 | 107 | 110 | PF13499 | 0.481 |
DOC_PP2B_LxvP_1 | 182 | 185 | PF13499 | 0.677 |
DOC_USP7_MATH_1 | 79 | 83 | PF00917 | 0.615 |
DOC_USP7_MATH_1 | 8 | 12 | PF00917 | 0.459 |
DOC_USP7_MATH_1 | 89 | 93 | PF00917 | 0.529 |
DOC_USP7_MATH_1 | 94 | 98 | PF00917 | 0.481 |
LIG_14-3-3_CanoR_1 | 37 | 44 | PF00244 | 0.431 |
LIG_Actin_WH2_2 | 100 | 115 | PF00022 | 0.498 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.577 |
LIG_FHA_1 | 17 | 23 | PF00498 | 0.474 |
LIG_FHA_1 | 28 | 34 | PF00498 | 0.490 |
LIG_FHA_1 | 48 | 54 | PF00498 | 0.392 |
LIG_FHA_1 | 79 | 85 | PF00498 | 0.616 |
LIG_HCF-1_HBM_1 | 121 | 124 | PF13415 | 0.411 |
LIG_IRF3_LxIS_1 | 18 | 24 | PF10401 | 0.451 |
LIG_LIR_Apic_2 | 51 | 57 | PF02991 | 0.500 |
LIG_LIR_Apic_2 | 69 | 73 | PF02991 | 0.468 |
LIG_LIR_Gen_1 | 121 | 131 | PF02991 | 0.461 |
LIG_LIR_Nem_3 | 125 | 131 | PF02991 | 0.424 |
LIG_LIR_Nem_3 | 24 | 29 | PF02991 | 0.388 |
LIG_PDZ_Class_1 | 213 | 218 | PF00595 | 0.441 |
LIG_SH2_CRK | 54 | 58 | PF00017 | 0.458 |
LIG_SH2_CRK | 70 | 74 | PF00017 | 0.534 |
LIG_SH2_GRB2like | 54 | 57 | PF00017 | 0.449 |
LIG_SH2_NCK_1 | 54 | 58 | PF00017 | 0.497 |
LIG_SH2_NCK_1 | 70 | 74 | PF00017 | 0.471 |
LIG_SH2_STAP1 | 124 | 128 | PF00017 | 0.452 |
LIG_SH2_STAP1 | 29 | 33 | PF00017 | 0.373 |
LIG_SH2_STAT5 | 128 | 131 | PF00017 | 0.368 |
LIG_SH2_STAT5 | 134 | 137 | PF00017 | 0.363 |
LIG_SH2_STAT5 | 29 | 32 | PF00017 | 0.356 |
LIG_SH2_STAT5 | 38 | 41 | PF00017 | 0.429 |
LIG_SH2_STAT5 | 54 | 57 | PF00017 | 0.449 |
LIG_SH3_3 | 145 | 151 | PF00018 | 0.452 |
LIG_SUMO_SIM_anti_2 | 19 | 24 | PF11976 | 0.439 |
LIG_SUMO_SIM_par_1 | 18 | 24 | PF11976 | 0.394 |
LIG_TRFH_1 | 70 | 74 | PF08558 | 0.547 |
MOD_GlcNHglycan | 11 | 14 | PF01048 | 0.505 |
MOD_GlcNHglycan | 206 | 209 | PF01048 | 0.561 |
MOD_GlcNHglycan | 211 | 214 | PF01048 | 0.616 |
MOD_GlcNHglycan | 215 | 218 | PF01048 | 0.735 |
MOD_GlcNHglycan | 23 | 26 | PF01048 | 0.351 |
MOD_GlcNHglycan | 75 | 78 | PF01048 | 0.657 |
MOD_GlcNHglycan | 81 | 84 | PF01048 | 0.680 |
MOD_GlcNHglycan | 97 | 100 | PF01048 | 0.653 |
MOD_GSK3_1 | 135 | 142 | PF00069 | 0.501 |
MOD_GSK3_1 | 209 | 216 | PF00069 | 0.654 |
MOD_GSK3_1 | 48 | 55 | PF00069 | 0.461 |
MOD_GSK3_1 | 90 | 97 | PF00069 | 0.636 |
MOD_NEK2_1 | 203 | 208 | PF00069 | 0.569 |
MOD_NEK2_1 | 21 | 26 | PF00069 | 0.389 |
MOD_PIKK_1 | 135 | 141 | PF00454 | 0.443 |
MOD_PKA_1 | 209 | 215 | PF00069 | 0.620 |
MOD_PKA_2 | 139 | 145 | PF00069 | 0.567 |
MOD_PKA_2 | 203 | 209 | PF00069 | 0.566 |
MOD_PKB_1 | 200 | 208 | PF00069 | 0.507 |
MOD_Plk_4 | 16 | 22 | PF00069 | 0.374 |
TRG_DiLeu_BaLyEn_6 | 1 | 6 | PF01217 | 0.525 |
TRG_ENDOCYTIC_2 | 124 | 127 | PF00928 | 0.466 |
TRG_ENDOCYTIC_2 | 128 | 131 | PF00928 | 0.408 |
TRG_ER_diArg_1 | 117 | 119 | PF00400 | 0.390 |
TRG_ER_diArg_1 | 159 | 162 | PF00400 | 0.602 |
TRG_ER_diArg_1 | 199 | 202 | PF00400 | 0.492 |
TRG_NLS_MonoExtC_3 | 199 | 204 | PF00514 | 0.447 |
TRG_NLS_MonoExtN_4 | 198 | 205 | PF00514 | 0.515 |
TRG_Pf-PMV_PEXEL_1 | 37 | 41 | PF00026 | 0.426 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I303 | Leptomonas seymouri | 67% | 98% |
A0A1X0NZI8 | Trypanosomatidae | 45% | 86% |
A0A3R7P4N9 | Trypanosoma rangeli | 48% | 93% |
A0A3S7WZA1 | Leishmania donovani | 92% | 94% |
A4HE95 | Leishmania braziliensis | 83% | 100% |
A4I1P1 | Leishmania infantum | 92% | 94% |
C9ZK90 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 46% | 100% |
Q4Q9P6 | Leishmania major | 85% | 100% |